Nerandomilast (BI 1015550) is an investigational oral drug that selectively inhibits phosphodiesterase 4B, exhibiting antifibrotic and immune-modulating effects. In previous...
Nerandomilast
Nerandomilast met its primary end point of absolute change from baseline in forced vital capacity (FVC) vs placebo in the...
